These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12127799)

  • 1. Roles of gamma interferon and tumor necrosis factor-alpha in shiga toxin lethality.
    Sasaki S; Omoe K; Tagawa Yi; Iwakura Y; Sekikawa K; Shinagawa K; Nakane A
    Microb Pathog; 2002 Jul; 33(1):43-7. PubMed ID: 12127799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.
    Lentz EK; Cherla RP; Jaspers V; Weeks BR; Tesh VL
    Infect Immun; 2010 Sep; 78(9):3689-99. PubMed ID: 20605983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
    Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
    Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin.
    Sood A; Mathew R; Trachtman H
    Biochem Biophys Res Commun; 2001 Apr; 283(1):36-41. PubMed ID: 11322764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.
    Park JY; Jeong YJ; Park SK; Yoon SJ; Choi S; Jeong DG; Chung SW; Lee BJ; Kim JH; Tesh VL; Lee MS; Park YJ
    Toxins (Basel); 2017 Oct; 9(10):. PubMed ID: 29027919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of anisodamine against Shiga toxin-1: inhibition of cytokine production and increase in the survival of mice.
    Zhang HM; Ou ZL; Gondaira F; Ohmura M; Kojio S; Yamamoto T
    J Lab Clin Med; 2001 Feb; 137(2):93-100. PubMed ID: 11174465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.
    Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S
    Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Shiga toxin-induced tumor necrosis factor-alpha production and gene expression in human monocytic cells by CV6209.
    Zhang HM; Ohmura M; Gondaira F; Yamamoto T
    Life Sci; 2001 Mar; 68(16):1931-7. PubMed ID: 11292071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
    Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
    Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.
    Flagler MJ; Strasser JE; Chalk CL; Weiss AA
    Infect Immun; 2007 Feb; 75(2):760-5. PubMed ID: 17101648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anisodamine inhibits shiga toxin type 2-mediated tumor necrosis factor-alpha production in vitro and in vivo.
    Zhang HM; Ou ZL; Yamamoto T
    Exp Biol Med (Maywood); 2001 Jun; 226(6):597-604. PubMed ID: 11395932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.
    Harrison LM; van Haaften WC; Tesh VL
    Infect Immun; 2004 May; 72(5):2618-27. PubMed ID: 15102770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
    Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
    Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
    Basu D; Tumer NE
    Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.
    Lentz EK; Leyva-Illades D; Lee MS; Cherla RP; Tesh VL
    Infect Immun; 2011 Sep; 79(9):3527-40. PubMed ID: 21708996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid apoptosis induced by Shiga toxin in HeLa cells.
    Fujii J; Matsui T; Heatherly DP; Schlegel KH; Lobo PI; Yutsudo T; Ciraolo GM; Morris RE; Obrig T
    Infect Immun; 2003 May; 71(5):2724-35. PubMed ID: 12704147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular injury induced in mice by intraperitoneal injection of Shiga-like toxins.
    Koshi R; Pulimood AB; Date A; Kang G; Acheson D; Mathan MM
    Indian J Med Res; 2001 Feb; 113():63-9. PubMed ID: 21901908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.